Bristol-Myers Set To Pay Shareholders $185M

Law360, New York (February 9, 2006, 12:00 AM EST) -- A judge has set the stage for Bristol-Myers Squibb Co. to hand out $185 million in a proposed settlement that would end a securities class action lawsuit brought by shareholders over an experimental heart drug the company touted as a future blockbuster, which later proved to be potentially fatal.

Earlier this week, U.S. District Judge Stanley Chesler gave his preliminary approval for a plan to create a $185 million settlement fund that will reimburse certain investors who purchased the global pharmaceutical company’s common stock between October...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.